11/03/2026
๐งฌ ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ๐ ๐ฎ๐๐๐ฒ๐ฟโข โ ๐ ๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น๐น๐ ๐ฉ๐ฎ๐น๐ถ๐ฑ๐ฎ๐๐ฒ๐ฑ ๐๐ป๐๐ฒ๐ด๐ฟ๐ฎ๐๐ฒ๐ฑ ๐ก๐๐ฆ ๐ฆ๐ผ๐น๐๐๐ถ๐ผ๐ป ๐ณ๐ผ๐ฟ ๐ฃ๐ฟ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐
CancerMasterโข, a 524-gene hybrid capture NGS panel developed by Celemics, has been analytically and clinically validated using real-world patient data from Severance Hospital.
The study demonstrates high concordance with TSO500, deep sequencing performance (~1,200ร coverage), and integrated analysis of SNV, CNV, Fusion, MSI, TMB, and viral biomarkers.